US FDA finalises combination drug/device product guidance
The US FDA has finalised its guidelines on cGMP and quality system compliance for drug and delivery device combination products.
The US FDA has finalised its guidelines on cGMP and quality system compliance for drug and delivery device combination products.
update
President elect Donald Trump has said he will bring drug manufacturing back to the US and introduce bidding measures to cut the amount the country spends on medicines.
The updated Simcyp Simulator features several enhanced models to help predict pharmacokinetic outcomes in virtual patient populations.
The “NCI Formulary” enables investigators to obtain investigational agents for testing in new preclinical or clinical studies.
update
FUJIFILM Diosynth Biotechnologies USA (FDBU) has selected SciQuest to automate ‘critical’ purchasing and accounts payable processes.
The asset acquisition adds seven patient service centers to LabCorps’ network of 120 patient service centers in the metropolitan New York City area.